Lymphoma Diagnosis And Treatment
49 researchers across 3 institutions
Research in lymphoma diagnosis and treatment focuses on understanding the cellular and molecular underpinnings of these blood cancers to develop more effective and personalized therapeutic strategies. Investigations explore novel diagnostic techniques, including advanced imaging and biomarker identification, to improve early detection and disease staging. Treatment research encompasses the evaluation of new chemotherapies, targeted agents, immunotherapies, and stem cell transplantation protocols. Studies also examine the mechanisms of drug resistance and the development of strategies to overcome it, alongside research into the long-term effects and quality of life for lymphoma survivors.
This work holds significant relevance for Arkansas by addressing cancer burdens within the state and contributing to the growth of its healthcare and biotechnology sectors. Improving diagnostic accuracy and treatment efficacy for lymphoma can lead to better patient outcomes and reduced healthcare costs. Furthermore, research into health disparities in cancer care can inform public health initiatives aimed at improving access to diagnosis and treatment for all Arkansans, particularly in underserved rural communities.
This area of study is inherently interdisciplinary, drawing upon expertise in cancer biology, pharmacology, immunology, and clinical medicine. It involves collaborations that span multiple institutions across Arkansas, integrating basic science discoveries with clinical applications and health outcomes research. The research also connects to fields such as immune response and inflammation, hematopoietic stem cell transplantation, and CAR-T cell therapy.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Jeannette Y. Lee | UAMS | 57 | 10,172 | High Impact | |
| Henry K. Wong | UAMS | 41 | 6,029 | High Impact | |
| Michael R. Bishop | UAMS | 38 | 6,577 | High Impact | |
| Ginell R. Post | UAMS | 21 | 1,752 | High Impact | |
| Jeanette Y. Lee | UAMS | 21 | 4,956 | High Impact | |
| Manit Munshi | UAMS | 19 | 1,459 | ||
| Donghoon Yoon | UAMS | 18 | 1,241 | ||
| Samantha Kendrick | UAMS | 16 | 1,773 | Grant PI | |
| Syed Hassan Mehdi | UAMS | 16 | 1,022 | ||
| Mark Manzano | UAMS | 15 | 1,309 | Grant PI | |
| Youzhong Yuan | UAMS | 15 | 942 | ||
| Muthu Veeraputhiran | UAMS | 10 | 364 | ||
| Stephen G. Jones | UAMS | 10 | 463 | ||
| Jeanette Y. Lee | UAMS | 9 | 710 | ||
| Soumya Pandey | UAMS | 8 | 195 | ||
| Appalanaidu Sasapu | UAMS | 7 | 1,586 | ||
| Ying-Zhi Xu | UAMS | 5 | 204 | ||
| Brad Baltz | University of Arkansas – Fort Smith | 5 | 87 | ||
| Mamatha Gaddam | UAMS | 4 | 60 | ||
| Alan Baltz | UAMS | 4 | 52 |
Related Research Areas
Connected Research Areas
Topics that share active collaborators with Lymphoma Diagnosis And Treatment in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 The University of Texas MD Anderson Cancer Center 7,155
- 2 Memorial Sloan Kettering Cancer Center 4,500
- 3 Dana-Farber Cancer Institute 3,450
- 4 Harvard University 3,116
- 5 Stanford University 3,048
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Lymphoma Diagnosis And Treatment.